Tag: IBD
TARGET PharmaSolutions And Bristol Myers Squibb Take Aim At Inflammatory Bowel Disease
TARGET PharmaSolutions, Inc., a company focused on real-world evidence, has announced a strategic partnership with Bristol Myers Squibb (BMS) for its TARGET-IBD study which includes a biorepository which its stakeholders can access for translational studies of viral resistance, genomics...
